Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Usage Information

An In Vitro Effect of Triiodothyronine on Rat Adipose Tissue
Martha Vaughan
Martha Vaughan
Published September 1, 1967
Citation Information: J Clin Invest. 1967;46(9):1482-1491. https://doi.org/10.1172/JCI105640.
View: Text | PDF
Research Article

An In Vitro Effect of Triiodothyronine on Rat Adipose Tissue

  • Text
  • PDF
Abstract

Triiodo-L-thyronine (T3) added in vitro to fat pads from normal, or propylthiouracil-treated rats enhanced the rate of release of glycerol and free fatty acids (FFA) in the presence of epinephrine. An effect of T3 was also demonstrated in the presence of adrenocorticotropic hormone (ACTH), thyroid-stimulating hormone, or glucagon in studies with tissue from normal rats. The minimal effective concentration of T3 was approximately 2.5 × 10-5 mole/liter for intact fat pads and 3 × 10-6 mole/liter for fat cells. With fat pads from propylthiouracil-treated rats the effect of T3 was not apparent until the 3rd hr of incubation. Enhancement of epinephrine-stimulated lipolysis by T3 was evident during the 1st hr of incubation of fat pads from normal rats, and fat cells responded almost immediately to the presence of T3. When added alone or in the presence of theophylline, 3′,5′-adenosine monophosphate or its dibutyryl derivative, T3 had little or no effect on lipolysis. The effect of T3 was observed with or without glucose in the medium, and was not inhibited by cycloheximide or actinomycin D. It did not persist when tissues, after incubation in the presence of T3 were transferred to medium without T3. No effect of T3 on glucose uptake in the presence of epinephrine, ACTH, or insulin was demonstrated.

Authors

Martha Vaughan

×

Usage data is cumulative from July 2024 through July 2025.

Usage JCI PMC
Text version 193 9
PDF 128 9
Scanned page 354 7
Citation downloads 74 0
Totals 749 25
Total Views 774
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts